These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 31138312)
21. Identification of Periostin as a Potential Biomarker in Gliomas by Database Mining. Faried A; Hermanto Y; Tjahjono FP; Valentino A; Arifin MZ World Neurosurg; 2020 Mar; 135():e137-e163. PubMed ID: 31785437 [TBL] [Abstract][Full Text] [Related]
22. EGFLAM correlates with cell proliferation, migration, invasion and poor prognosis in glioblastoma. Chen J; Zhang J; Hong L; Zhou Y Cancer Biomark; 2019; 24(3):343-350. PubMed ID: 30829611 [TBL] [Abstract][Full Text] [Related]
23. Molecular classification of IDH-mutant glioblastomas based on gene expression profiles. Wu F; Chai RC; Wang Z; Liu YQ; Zhao Z; Li GZ; Jiang HY Carcinogenesis; 2019 Jul; 40(7):853-860. PubMed ID: 30877769 [TBL] [Abstract][Full Text] [Related]
24. The promising novel biomarkers and candidate small molecule drugs in lower-grade glioma: Evidence from bioinformatics analysis of high-throughput data. Zhang B; Wu Q; Xu R; Hu X; Sun Y; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Wang Z; Zhou YL J Cell Biochem; 2019 Sep; 120(9):15106-15118. PubMed ID: 31020692 [TBL] [Abstract][Full Text] [Related]
25. Methylated of genes behaving as potential biomarkers in evaluating malignant degree of glioblastoma. Wen WS; Hu SL; Ai Z; Mou L; Lu JM; Li S J Cell Physiol; 2017 Dec; 232(12):3622-3630. PubMed ID: 28145562 [TBL] [Abstract][Full Text] [Related]
26. Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis. Reddy SP; Britto R; Vinnakota K; Aparna H; Sreepathi HK; Thota B; Kumari A; Shilpa BM; Vrinda M; Umesh S; Samuel C; Shetty M; Tandon A; Pandey P; Hegde S; Hegde AS; Balasubramaniam A; Chandramouli BA; Santosh V; Kondaiah P; Somasundaram K; Rao MR Clin Cancer Res; 2008 May; 14(10):2978-87. PubMed ID: 18483363 [TBL] [Abstract][Full Text] [Related]
28. Mining TCGA database for genes of prognostic value in glioblastoma microenvironment. Jia D; Li S; Li D; Xue H; Yang D; Liu Y Aging (Albany NY); 2018 Apr; 10(4):592-605. PubMed ID: 29676997 [TBL] [Abstract][Full Text] [Related]
29. Identification of biomarkers associated with extracellular vesicles based on an integrative pan-cancer bioinformatics analysis. Wang Q; Yu C Med Oncol; 2020 Aug; 37(9):79. PubMed ID: 32749536 [TBL] [Abstract][Full Text] [Related]
30. NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma. Guo Q; Han N; Shi L; Yang L; Zhang X; Zhou Y; Yu S; Zhang M Oncol Rep; 2019 Sep; 42(3):963-972. PubMed ID: 31322259 [TBL] [Abstract][Full Text] [Related]
31. mRNA markers for survival prediction in glioblastoma multiforme patients: a systematic review with bioinformatic analyses. Azimi P; Yazdanian T; Ahmadiani A BMC Cancer; 2024 May; 24(1):612. PubMed ID: 38773447 [TBL] [Abstract][Full Text] [Related]
32. A novel strategy of integrated microarray analysis identifies CENPA, CDK1 and CDC20 as a cluster of diagnostic biomarkers in lung adenocarcinoma. Liu WT; Wang Y; Zhang J; Ye F; Huang XH; Li B; He QY Cancer Lett; 2018 Jul; 425():43-53. PubMed ID: 29608985 [TBL] [Abstract][Full Text] [Related]
33. Chromatin remodeler HELLS maintains glioma stem cells through E2F3 and MYC. Zhang G; Dong Z; Prager BC; Kim LJ; Wu Q; Gimple RC; Wang X; Bao S; Hamerlik P; Rich JN JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30779712 [TBL] [Abstract][Full Text] [Related]
34. Identification of a key glioblastoma candidate gene, FUBP3, based on weighted gene co-expression network analysis. Li J; Zhang Z; Guo K; Wu S; Guo C; Zhang X; Wang Z BMC Neurol; 2022 Apr; 22(1):139. PubMed ID: 35413821 [TBL] [Abstract][Full Text] [Related]
36. Identification of N Wang W; Li J; Lin F; Guo J; Zhao J Neurosurg Rev; 2021 Feb; 44(1):463-470. PubMed ID: 31938968 [TBL] [Abstract][Full Text] [Related]
37. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas. Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114 [TBL] [Abstract][Full Text] [Related]
38. Identification of Potential Biomarkers in Glioblastoma through Bioinformatic Analysis and Evaluating Their Prognostic Value. Zhou Y; Yang L; Zhang X; Chen R; Chen X; Tang W; Zhang M Biomed Res Int; 2019; 2019():6581576. PubMed ID: 31119182 [TBL] [Abstract][Full Text] [Related]
39. Stratification according to recursive partitioning analysis predicts outcome in newly diagnosed glioblastomas. Yang F; Yang P; Zhang C; Wang Y; Zhang W; Hu H; Wang Z; Qiu X; Jiang T Oncotarget; 2017 Jun; 8(26):42974-42982. PubMed ID: 28496000 [TBL] [Abstract][Full Text] [Related]
40. A multi-cancer mesenchymal transition gene expression signature is associated with prolonged time to recurrence in glioblastoma. Cheng WY; Kandel JJ; Yamashiro DJ; Canoll P; Anastassiou D PLoS One; 2012; 7(4):e34705. PubMed ID: 22493711 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]